Clinical Trials Logo

Clinical Trial Summary

Severe pre-eclamptic toxemia has a high incidence of renal complications. Rapid diagnosis and termination of pregnancy are still the gold standard main treatment for pre-eclampsia. Rapid control of blood pressure showed to provide protection against many adverse effects of preeclampsia as intracranial hemorrhage, subcapsular hepatic hematoma and acute kidney injury (AKI). In Assiut university hospital ICU regimen, glyceryl trinitrate (GTN) was used primarily for this purpose. But it was accused in many cases as a cause for AKI without any other organ damage along with the severe preeclampsia disease. Some previous studies supported this assumption as , Ying-Hsuan .T. et.,al during their study of GTN on renal outcome during cardiopulmonary bypass in cardiac surgery. Phentolamine infusion is a new rising alternative for an old drug with a high safety profile. In this research protocol the researchers will study comparative effect of glyceryl trinitrate (GTN) versus phentolamine on renal outcome in severe pre-eclampsia patients during their stay in obstetric ICU.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05687669
Study type Interventional
Source Assiut University
Contact
Status Not yet recruiting
Phase Phase 4
Start date January 12, 2023
Completion date June 12, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06445543 - Nutrition Optimization and Community Upliftment for Postpartum Recovery: Intervention to Support Healing After Hypertensive Disorders of Pregnancy N/A
Recruiting NCT05863962 - Comparative Effects of Jacobson's Relaxation Techniques and Stretching Exercises in Preeclampsia N/A
Recruiting NCT04777097 - Blood Loss and Preeclampsia
Recruiting NCT05679206 - Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
Not yet recruiting NCT06452498 - Preeclampsia Intervention Netherlands Phase 3